A plain-English guide for home health agency owners considering a sale in Texas and Oklahoma. How valuation works, what PE buyers pay, and regulatory considerations.
Selling a home health agency is like selling a ship. The hull has to transfer. The crew has to transfer. And the navigation licenses, the ones that authorize you to operate in specific waters under specific conditions, those have to transfer too. Get any one of those wrong and the whole thing sinks.
I have seen deals blow up at close because a state deficiency from three years ago surfaced in week three of diligence. The seller knew about it. The seller had resolved it. The seller just decided not to bring it up early. And when the buyer's attorney found it in the state database, that was the end of that conversation. A two-year process, a seven-figure outcome, gone. Because of a paperwork decision made in a hurry.
Home health M&A is more complex than most business sales. Medicare certification, state licensure, payer mix, and regulatory history all factor into valuation. The difference between a 4x deal and a 7x deal often comes down to factors that have nothing to do with revenue size. Here is what actually drives those outcomes.
Agencies above $2M in revenue are typically valued on EBITDA multiples, generally 4x–8x depending on payer mix, accreditation, and operational quality. Smaller agencies are sometimes valued on a revenue multiple, 0.5x–1.2x gross revenue, but institutional buyers prefer the EBITDA method.
A practical example: a home health agency doing $4.5M in revenue with a 60% Medicare, 25% managed care, 15% private pay mix and $600K in EBITDA might trade at 5x–6x, a $3M–$3.6M outcome. The same agency with 40% private pay and 35% managed care might trade at 6x–7x, a $3.6M–$4.2M outcome. Same EBITDA. Different payer mix. Meaningfully different price.
Medicare rates are regulated and subject to reimbursement risk. Managed care contracts are negotiated and more predictable. Private pay is premium and signals a business that is not dependent on government reimbursement schedules.
Buyers model future cash flow based on payer mix and they discount heavily for Medicare concentration. An agency that has been actively diversifying its payer mix, even in the 12–24 months before a sale, can improve both its valuation multiple and the range of buyers interested in it.
CHAP or Joint Commission accreditation adds measurable value. It signals operational discipline and reduces the buyer's diligence risk. If you are not accredited and you are thinking about selling in the next two years, accreditation is worth pursuing now.
State licensure transferability must be confirmed early. A change in ownership for a Medicare-certified home health agency requires notification to CMS and can affect deal structure and timing. This is a transaction variable that surprises many sellers. Buyers who have navigated CHOW processes before move faster and with fewer complications than those who have not.
Your OASIS data and star ratings are visible to buyers and to buyers' lenders. A strong star rating supports valuation. A pattern of deficiencies creates skepticism that requires a very good explanation. Get ahead of it. Do not let a buyer find something in week three that you knew about in year one.
Caregiver turnover is an industry-wide challenge and buyers understand that. What they are actually evaluating is leadership stability: the clinical director, the administrator, the billing manager. These are the people who ensure compliance, manage payer relationships, and keep the referral network functioning after the founder leaves.
Retention agreements for key clinical leadership are standard in home health acquisitions. If you have strong leadership in place and they are committed to staying, that is a real signal to every buyer who looks at your business. If the answer is "I am not sure," that is also a signal. A different one.
SBA 7(a) can be used for home health agency acquisitions, but structuring requires care. The Medicare provider agreement assumption needs to be addressed in the deal structure. Working capital requirements are often higher than in other business types. And certain payer relationships create complexity that experienced buyers work through more efficiently than first-time acquirers.
For larger acquisitions, or where SBA alone does not cover the full financing need, private credit or mezzanine debt can supplement the capital structure. We work with private credit providers who understand healthcare services specifically, not generic commercial lenders trying to figure out the sector as they go.
Texas is one of the largest home health markets in the country. STAR+PLUS, Texas's Medicaid managed care program, creates ongoing demand across DFW, Houston, San Antonio, and the Rio Grande Valley. Oklahoma is also active, particularly for agencies serving rural Medicare populations. Both states have active SBA lenders with experience in healthcare services transactions.
Berkman Woods acquires home health agencies as part of our healthcare investment strategy in Texas and Oklahoma. We understand the regulatory nuances, have worked through CHOW processes, and move efficiently once we have conviction. If you are thinking about selling your agency and want a direct conversation about what it is worth, that conversation is confidential and starts here.
Related: Healthcare · For Business Owners
